Sign Up to Receive Your Personalised Learning Resources
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Clinical advancements and key presentations: ESGO 2024
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches
Gauging the Online Public Interest in Breast Cancer in Pakistan
Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results
A New Frontier in the Treatment of Epidermal Growth Factor Receptor-mutated Non–Small-Cell Lung Cancer: Amivantamab-vmjw and Chemotherapy
Foreword – touchREVIEWS in Oncology & Haematology, Volume 20, Issue 2, 2024
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
ASCO #GU25: Top trials you need to know about in prostate cancer
Overcoming Barriers in Liver Cancer Care: An Interview with Larry R Holden, CEO of Global Liver Institute
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
View
Advancing care in myelodysplastic syndromes: Expert insights from Prof. Pierre Fenaux
View
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
View
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
View
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
View
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches
View
FUTURE LEADERS: Shaping the future of melanoma and sarcoma with Dr Rodrigo Munhoz
View
Breast cancer highlights: DESTINY-Breast06, postMONARCH, TBCRC 048
View
Project Cure CRC ignites innovation in 2025 with $10.5 million in research, K-SPY debut & renewed RFP
View
Fruquintinib in Patients with Previously Treated Metastatic Colorectal Cancer
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
